Recombinant EGF-CRM197 tumor therapeutic vaccine
重组EGF-CRM197肿瘤治疗性疫苗
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant EGF-CRM197 tumor therapeutic vaccine
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Humantech Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShanghai Humantech Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A